The global insulin analog market size was valued at USD 16.99 billion in 2024 and is predicted to hit around USD 25.29 ...
A groundbreaking development in diabetes management may soon provide needle-averse patients with a painless alternative to insulin injections. Researchers have developed a skin gel capable of ...
According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...
In mice with type 1 diabetes, a topical dose of OP-I was smeared onto the skin. Blood glucose levels fell to a normal range ...
A groundbreaking polymer-based skin cream shows promise in replacing painful daily insulin injections for diabetes management ...
In a move aimed at expanding affordable treatment options for millions of Americans living with diabetes, Biocon Biologics Ltd. and nonprofit generic drug manufacturer Civica, Inc. have announced a ...
A Prescription Drug User Fee Act target date of May 29, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...
A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback